On May 6th, 2019 presenter Dr. Susan Crocker, a clinical cytogeneticist and Director of the Cytogenetics Laborartory at Kingston Health Sciences Centre (KHSC)reviewed aspects of the current knowledge of neurogenesis; explores the role of cytogenomic aberrations and their presence in the neuropathology of the brain and discusses the utility of recent advances in molecular testing and their potential application to screening for neurodegenerative disease. Stay tuned for the recording of the presentation here.

The authors described the findings of a cross-sectional study which provided empirical evidence that prolonged use of inhaled or ingested street cannabis in patients with MS is associated with poorer performance on cognitive domains commonly affected in this population. 8 pages. Last reviewed March 2019.

This publication describes the findings of a review of medical marijuana (1948-2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy and movement disorders. 8 pages. Last reviewed March 2019.

This publication outlines the standards of practice for all Speech-Language Pathologists in Ontario when providing services to individuals who present with acquired cognitive communication disorders. 50 pages. Last reviewed January, 2019.

Wed. Oct. 3rd, 2018 from 2-3pm EDT. Join presenters Barb Vermeulen & Johnathan Werynski as they discuss the basics of medical cannabis as well as an in depth look at available products, usage, administration methods and access to safe medication with an emphasis to the management of MS symptoms. To learn more or register, click here.

November 30, 2018 from 12-1PM EDT. Join presenter Dr. Cathy Craven for this Beyond the Break webinar presentation.  For more details or the OTN link to join click here.

Thursday, October 18th from 9:30 AM to 5:00 PM (EDT) located at the Baycrest Centre in Toronto, Ontario. This workshop led by Dr. Brian Levine will provide the latest clinical-scientific information concerning the assessment of executive functions and evidence-based rehabilitation with Goal Management Training® (GMT). To register, click here.

Tuesday, July 10, 2018 from 2:00-3:30 PM EDT. This webinar presented by Karen Henderson, will provide practical tips on planning for and meeting both the little and big planning challenges that face us all—from when is the right time to retire, to re-evaluating your location, to an easy way to keep your advance directive current. Helpful resources will also be provided. Register here.

This report presents key findings on physical, mental, and social aspects of aging using data collected from 50,000 Canadians aged 45-85. It highlights insights related to: physical and psychological health, loneliness and social isolation, caregiving and care receiving, transportation and mobility, work and retirement, physical function, disability and falls, lesbian, gay and bisexual aging, and lifestyle and behaviour, among others. 210 pages. Last reviewed May 2018.

Tuesday May 29th from 3-4:30 PM EDT.  Join Amy Semaka for this Multiple Sclerosis Society of Canada event. During this webinar Amy will discuss drug development and patient safety, biosimilars and their regulation, recent drug news and future prospects, drug support programs, the role for atypical and controversial therapies, patient advocacy issues and the role of the pharmacist in MS management. For more information or to register click here.

Pages